Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

More articles from Notice of Retraction

  • You have access
    Notice of Retraction: Harada S, Yamazaki Y, and Tokuyama S (2013) Orexin-A Suppresses Postischemic Glucose Intolerance and Neuronal Damage through Hypothalamic Brain-Derived Neurotrophic Factor, J Pharmacol Exp Ther, 344: 276-285; DOI: https://doi.org/10.1124/jpet.112.199604
    Journal of Pharmacology and Experimental Therapeutics November 2020, 375 (2) 397; DOI: https://doi.org/10.1124/jpet.112.199604retraction
  • You have access
    Re: Schneider-Stock R, Diab-Assef M, Rohrbeck A, Foltzer-Jourdainne C, Boltze C, Hartig R, Schönfeld P, Roessner A, and Gali-Muhtasib H (2005) 5-aza-Cytidine Is a Potent Inhibitor of DNA Methyltransferase 3a and Induces Apoptosis in HCT-116 Colon Cancer Cells via Gadd45- and p53-Dependent Mechanisms. J Pharmacol Exp Ther February 2005 312:525–536; doi:10.1124/jpet.104.074195
    Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 90; DOI: https://doi.org/10.1124/jpet.113.074195retraction
  • You have access
    Re: Norman AB, Tabet MR, Norman MK, and Tsibulsky VL (2014) Maintained Cocaine Self-Administration Is Determined by Quantal Responses: Implications for the Measurement of Antagonist Potency. J Pharmacol Exp Ther 348:311–315; doi:10.1124/jpet.113.210690
    Journal of Pharmacology and Experimental Therapeutics August 2016, 358 (2) 241; DOI: https://doi.org/10.1124/jpet.113.210690retraction
  • You have access
    Re: Magierowski M, Jasnos K, Pawlik M, Krzysiek-Maczka G, Ptak-Belowska A, Olszanecki R, Kwiecien S, Korbut R, and Brzozowski T (2013) Role of Angiotensin-(1–7) in Gastroprotection against Stress-Induced Ulcerogenesis. The Involvement of Mas Receptor, Nitric Oxide, Prostaglandins, and Sensory Neuropeptides. J Pharmacol Exp Ther 347:717–726; doi:10.1124/jpet.113.207233
    Journal of Pharmacology and Experimental Therapeutics June 2015, 353 (3) 563; DOI: https://doi.org/10.1124/jpet.115.06er15
  • You have access
    Re: Kadam RS and Kompella UB (2010) Influence of Lipophilicity on Drug Partitioning into Sclera, Choroid-Retinal Pigment Epithelium, Retina, Trabecular Meshwork, and Optic Nerve. J Pharmacol Exp Ther 332:1107–1120; doi:10.1124/jpet.109.161570
    Journal of Pharmacology and Experimental Therapeutics February 2015, 352 (2) 326; DOI: https://doi.org/10.1124/jpet.114.02er15
  • You have access
    Re: Nakajima A, Ueda K, Takaoka M, Yoshimi Y, and Matsumura Y (2006) Opposite Effects of Pre- and Postischemic Treatments with Nitric Oxide Donor on Ischemia/Reperfusion-Induced Renal Injury. J Pharmacol Exp Ther 316:1038–1046; doi:10.1124/jpet.105.092049
    Journal of Pharmacology and Experimental Therapeutics May 2014, 349 (2) 345; DOI: https://doi.org/10.1124/jpet.114.05er14a
  • You have access
    Re: Kobuchi S, Tanaka R, Shintani T, Suzuki R, Tsutsui H, Ohkita M, Ayajiki K, and Matsumura Y (2011) Mechanisms Underlying the Renoprotective Effect of GABA against Ischemia/Reperfusion-Induced Renal Injury in Rats. J Pharmacol Exp Ther 338:767–774; doi:10.1124/jpet.111.180174
    Journal of Pharmacology and Experimental Therapeutics May 2014, 349 (2) 347; DOI: https://doi.org/10.1124/jpet.114.05er14c
  • You have access
    Re: Ueda K, Tsuju F, Hirata T, Ueda K, Murai M, Aono H, Takaoka M, and Matsumura Y (2009) Preventive Effect of SA13353 [1-[2-(1-Adamantyl)ethyl]-1-pentyl-3-[3-(4-pyridyl)propyl]urea], a Novel Transient Receptor Potential Vanilloid 1 Agonist, on Ischemia/Reperfusion-Induced Renal Injury in Rats. J Pharmacol Exp Ther 329:202–209; doi:10.1124/jpet.108.146241
    Journal of Pharmacology and Experimental Therapeutics May 2014, 349 (2) 346; DOI: https://doi.org/10.1124/jpet.114.05er14b
  • You have access
    Re: Yamashita J, Itoh M, Kuro T, Kobayashi Y, Ogata M, Takaoka M, and Matsumura Y (2001) Pre- or Post-Ischemic Treatment with a Novel Na+/Ca2+ Exchange Inhibitor, KB-R7943, Shows Renal Protective Effects in Rats with Ischemic Acute Renal Failure. J Pharmacol Exp Ther 296:412–419
    Journal of Pharmacology and Experimental Therapeutics May 2014, 349 (2) 344; DOI: https://doi.org/10.1124/jpet.114.05er14
  • You have access
    Re: Furutani T, Takeyama K-i., Tanabe M, Koutoku H, Ito S, Taniguchi N, Suzuki E, Kudoh M, Shibasaki M, Shikama H, and Kato S (2005) Human expanded polyglutamine androgen receptor mutants in neurodegeneration as a novel ligand target. J Pharmacol Exp Ther 315:545–552; doi:10.1124/jpet.105.087643
    Journal of Pharmacology and Experimental Therapeutics March 2014, 348 (3) 493; DOI: https://doi.org/10.1124/jpet.114.03er14b

Pages

  • Next
  • 1
  • 2
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics